175 related articles for article (PubMed ID: 20413362)
1. The impact of Kaposi sarcoma and non-Hodgkin lymphoma on mortality of people with AIDS in the highly active antiretroviral therapies era.
Serraino D; De Paoli A; Zucchetto A; Pennazza S; Bruzzone S; Spina M; De Paoli P; Rezza G; Dal Maso L; Suligoi B
Cancer Epidemiol; 2010 Jun; 34(3):257-61. PubMed ID: 20413362
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.
Bonnet F; Balestre E; Thiébaut R; Morlat P; Pellegrin JL; Neau D; Dabis F;
Clin Infect Dis; 2006 Feb; 42(3):411-7. PubMed ID: 16392091
[TBL] [Abstract][Full Text] [Related]
3. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
Gingues S; Gill MJ
HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
[TBL] [Abstract][Full Text] [Related]
4. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
5. Survival after cancer diagnosis in persons with AIDS.
Biggar RJ; Engels EA; Ly S; Kahn A; Schymura MJ; Sackoff J; Virgo P; Pfeiffer RM
J Acquir Immune Defic Syndr; 2005 Jul; 39(3):293-9. PubMed ID: 15980688
[TBL] [Abstract][Full Text] [Related]
6. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
Cheung MC; Pantanowitz L; Dezube BJ
Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology of acquired immunodeficiency syndrome malignancies.
Goedert JJ
Semin Oncol; 2000 Aug; 27(4):390-401. PubMed ID: 10950365
[TBL] [Abstract][Full Text] [Related]
8. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
9. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
[TBL] [Abstract][Full Text] [Related]
10. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival.
Diamond C; Taylor TH; Aboumrad T; Anton-Culver H
Cancer; 2006 Jan; 106(1):128-35. PubMed ID: 16329140
[TBL] [Abstract][Full Text] [Related]
11. AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals.
Nasti G; Talamini R; Antinori A; Martellotta F; Jacchetti G; Chiodo F; Ballardini G; Stoppini L; Di Perri G; Mena M; Tavio M; Vaccher E; D'Arminio Monforte A; Tirelli U;
J Clin Oncol; 2003 Aug; 21(15):2876-82. PubMed ID: 12885804
[TBL] [Abstract][Full Text] [Related]
12. Changing incidence of AIDS-related Kaposi sarcoma and non-Hodgkin lymphoma in Ontario, Canada.
Bahl S; Theis B; Nishri D; Marrett LD
Cancer Causes Control; 2008 Dec; 19(10):1251-8. PubMed ID: 18618279
[TBL] [Abstract][Full Text] [Related]
13. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
[TBL] [Abstract][Full Text] [Related]
14. [AIDS associated cancers in the era of highly active antiretroviral therapy (HAART)].
Tserenpuntsag B; Kołacińska A; Jabłonowska E
Przegl Epidemiol; 2007; 61(3):529-34. PubMed ID: 18069390
[TBL] [Abstract][Full Text] [Related]
15. Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy.
Gallafent JH; Buskin SE; De Turk PB; Aboulafia DM
J Clin Oncol; 2005 Feb; 23(6):1253-60. PubMed ID: 15718323
[TBL] [Abstract][Full Text] [Related]
16. AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.
Cornejo-Juárez P; Volkow-Fernández P; Avilés-Salas A; Calderón-Flores E
Rev Invest Clin; 2008; 60(5):375-81. PubMed ID: 19227434
[TBL] [Abstract][Full Text] [Related]
17. Survival after cancer in Italian persons with AIDS, 1986-2005: a population-based estimation.
Dal Maso L; Suligoi B; Franceschi S; Braga C; Buzzoni C; Polesel J; Zucchetto A; Piselli P; Falcini F; Caldarella A; Zanetti R; Vercelli M; Guzzinati S; Russo A; Tagliabue G; Iachetta F; Ferretti S; Limina RM; Mangone L; Michiara M; Stracci F; Pirino DR; Piffer S; Giacomin A; Vitarelli S; Mazzoleni G; Iannelli A; Contrino ML; Fusco M; Tumino R; Fanetti AC; De Paoli P; Decarli A; Serraino D;
J Acquir Immune Defic Syndr; 2014 Aug; 66(4):428-35. PubMed ID: 24798769
[TBL] [Abstract][Full Text] [Related]
18. Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma.
Nasti G; Martellotta F; Berretta M; Mena M; Fasan M; Di Perri G; Talamini R; Pagano G; Montroni M; Cinelli R; Vaccher E; D'Arminio Monforte A; Tirelli U; ;
Cancer; 2003 Dec; 98(11):2440-6. PubMed ID: 14635079
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
[TBL] [Abstract][Full Text] [Related]
20. Opportunistic malignancies and the acquired immunodeficiency syndrome.
Mueller N; Hatzakis A
Princess Takamatsu Symp; 1987; 18():159-71. PubMed ID: 3506539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
